Search research articles
Contact Us
Filters
Showing results (161-170 of 231) with videos related to
Page
of 24
Sort By:
BMJ Quality & Safety
|
April 24, 2021
Handoff improvement and adverse event reduction programme implementation in paediatric intensive care units in Argentina: a stepped-wedge trial
Facundo Jorro-Barón, Inés Suarez-Anzorena, Rodrigo Burgos-Pratx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2009
Epigenetic regulation of microRNAs in acute lymphoblastic leukemia
Jose Roman-Gomez, Xabier Agirre, Antonio Jiménez-Velasco, et al.
British Journal of Haematology
|
November 20, 2020
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study
Ajai Chari, Paula Rodriguez-Otero, Helen McCarthy, et al.
British Journal of Haematology
|
October 21, 2021
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, et al.
Hospital Pediatrics
|
May 7, 2025
Improving Antibiotic Use in Pediatric Hospitals in Argentina: A Quality Improvement Study
Facundo Jorro-Baron, Cecilia Echave, Viviana Rodriguez, et al.
Nature Communications
|
December 12, 2025
A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial
Nicolas Bonnet, Maria Rosario Capeding, Léa Siegwald, et al.
Journal of Medical Economics
|
February 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
Meletios A Dimopoulos, Mario Boccadoro, Hermann Einsele, et al.
The Journal of Infectious Diseases
|
February 1, 2025
A Comparative Analysis of Universal and Sentinel Surveillance Data for Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020-2022)
Lidia Redondo-Bravo, Kinda Zureick, Carla Voto, et al.
Leukemia
|
June 14, 2023
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
Enrique M Ocio, Aurore Perrot, Pierre Bories, et al.
Blood Cancer Journal
|
July 10, 2024
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19
Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 231) with videos related to
Sort By:
Page
of 24
BMJ Quality & Safety
|
April 24, 2021
Handoff improvement and adverse event reduction programme implementation in paediatric intensive care units in Argentina: a stepped-wedge trial
Facundo Jorro-Barón, Inés Suarez-Anzorena, Rodrigo Burgos-Pratx, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2009
Epigenetic regulation of microRNAs in acute lymphoblastic leukemia
Jose Roman-Gomez, Xabier Agirre, Antonio Jiménez-Velasco, et al.
British Journal of Haematology
|
November 20, 2020
Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study
Ajai Chari, Paula Rodriguez-Otero, Helen McCarthy, et al.
British Journal of Haematology
|
October 21, 2021
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, et al.
Hospital Pediatrics
|
May 7, 2025
Improving Antibiotic Use in Pediatric Hospitals in Argentina: A Quality Improvement Study
Facundo Jorro-Baron, Cecilia Echave, Viviana Rodriguez, et al.
Nature Communications
|
December 12, 2025
A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial
Nicolas Bonnet, Maria Rosario Capeding, Léa Siegwald, et al.
Journal of Medical Economics
|
February 17, 2026
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
Meletios A Dimopoulos, Mario Boccadoro, Hermann Einsele, et al.
The Journal of Infectious Diseases
|
February 1, 2025
A Comparative Analysis of Universal and Sentinel Surveillance Data for Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020-2022)
Lidia Redondo-Bravo, Kinda Zureick, Carla Voto, et al.
Leukemia
|
June 14, 2023
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation
Enrique M Ocio, Aurore Perrot, Pierre Bories, et al.
Blood Cancer Journal
|
July 10, 2024
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19
Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, et al.
Page
of 24